Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04938180
Title A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AmMax Bio, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries POL | HUN


No variant requirements are available.